Uptravi 1600MCG tab
Ended Awarded Last action
- Contract number
- 36C26025F0209
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $197,168
Award facts
- Contract value 100% obligated
- $197,167.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $2,923 | |
| Original award | $194,244 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a $197,167.80 delivery order to Actelion Pharmaceuticals US, Inc. for the supply of UPTRAVI (selexipag) 1600 microgram tablets, reflecting a 2026 price increase. This firm fixed-price delivery order, with an ultimate completion date of July 20, 2026, represents a single transaction under Actelion's broader Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), valued at $219.1 million and effective through July 31, 2029. The contract carries no set-aside designation and requires performance at a location in Bartlett, Tennessee.
Actelion Pharmaceuticals US, Inc. serves as the sole prime contractor with no subcontractor involvement identified. The company specializes in rare disease pharmaceuticals, particularly pulmonary arterial hypertension treatments, and maintains an established presence across multiple Veterans Integrated Service Networks and Federal Bureau of Prisons facilities. This delivery order exemplifies the recurring procurement pattern through which the VA and other federal healthcare agencies obtain specialized medications in quantities tailored to patient populations, utilizing pre-negotiated pricing structures that incorporate annual Public Law adjustments to manage costs effectively across the federal healthcare system.
Quick answers
Who was awarded contract 36C26025F0209?
36C26025F0209 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 21, 2025.
How much is contract 36C26025F0209 worth?
The government has obligated $197,168 on 36C26025F0209.
Is contract 36C26025F0209 an order under another contract?
Yes. 36C26025F0209 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0209 competed?
The extent of competition for 36C26025F0209 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award